To determine the primary site of abnormal constitutive production of IFN-α in individuals with AGS, we first quantified IFN-α concentrations using Simoa from paired blood-CSF samples in control individuals (Figure 1A). This evidence concerns the gene IFNA1 and Aicardi-Goutieres syndrome.